{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T11:02:48Z","timestamp":1788433368556,"version":"build-2803163510"},"reference-count":34,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004348","name":"Stockholms L\u00c3\u00a4ns Landsting","doi-asserted-by":"publisher","award":["20160597"],"award-info":[{"award-number":["20160597"]}],"id":[{"id":"10.13039\/501100004348","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.cmi.2019.12.017","type":"journal-article","created":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T07:33:16Z","timestamp":1577863996000},"page":"1092.e1-1092.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["5-Nitroimidazole refractory giardiasis is common in Matanzas, Cuba and effectively treated by secnidazole plus high-dose mebendazole or quinacrine: a prospective observational cohort study"],"prefix":"10.1016","volume":"26","author":[{"given":"R.","family":"Ca\u00f1ete","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.L.","family":"Noda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Brito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Herrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.-E.","family":"Kofoed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Ursing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2019.12.017_bib1","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.mib.2016.07.019","article-title":"An up-date on Giardia and giardiasis","volume":"34","author":"Einarsson","year":"2016","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.cmi.2019.12.017_bib2","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.pt.2009.11.010","article-title":"Giardiasis \u2013 why do the symptoms sometimes never stop?","volume":"26","author":"Robertson","year":"2010","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.cmi.2019.12.017_bib3","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.2147\/IDR.S141468","article-title":"Treatment-refractory giardiasis: challenges and solutions","volume":"11","author":"Lalle","year":"2018","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.cmi.2019.12.017_bib4","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/jpids\/piw082","article-title":"Determinants and impact of Giardia infection in the first 2 years of life in the MAL-ED Birth Cohort","volume":"6","author":"Rogawski","year":"2017","journal-title":"J\u00a0Pediatr Infect Dis Soc"},{"key":"10.1016\/j.cmi.2019.12.017_bib5","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.pt.2008.06.008","article-title":"Cuban parasitology in review: a revolutionary triumph","volume":"24","author":"Rivero","year":"2008","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.cmi.2019.12.017_bib6","first-page":"377","article-title":"Prevalence, risk factors and clinical features associated with intestinal parasitic infections in children from San Juan y Martinez, Pinar del Rio, Cuba","volume":"57","author":"Escobedo","year":"2008","journal-title":"West Indian Med J"},{"key":"10.1016\/j.cmi.2019.12.017_bib7","first-page":"361","article-title":"Prevalence and factors associated with intestinal parasitic infection among school children from Jag\u00fcey Grande Municipality in Matanzas Province, Cuba","volume":"66","author":"Ca\u00f1ete","year":"2017","journal-title":"West Ind Med J"},{"key":"10.1016\/j.cmi.2019.12.017_bib8","doi-asserted-by":"crossref","first-page":"e51394","DOI":"10.1371\/journal.pone.0051394","article-title":"Intestinal parasites in children from a day care centre in Matanzas City, Cuba","author":"Canete","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.cmi.2019.12.017_bib9","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.curtheres.2018.11.002","article-title":"Effectiveness and tolerability of 3-day mebendazole treatment of Giardia duodenalis infection in adults and children: two prospective, open-label phase IV Trials","volume":"89","author":"Canete","year":"2018","journal-title":"Curr Ther Res Clin Exp"},{"key":"10.1016\/j.cmi.2019.12.017_bib10","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.biotechadv.2015.04.009","article-title":"Drug resistance in Giardia duodenalis","volume":"33","author":"Ansell","year":"2015","journal-title":"Biotechnol Adv"},{"key":"10.1016\/j.cmi.2019.12.017_bib11","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.cmi.2015.04.019","article-title":"Increased incidence of nitroimidazole-refractory giardiasis at the hospital for tropical diseases, London: 2008\u20132013","volume":"21","author":"Nabarro","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2019.12.017_bib12","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cmi.2017.05.028","article-title":"Nitroimidazole-refractory giardiasis: a growing problem requiring rational solutions","volume":"24","author":"Carter","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2019.12.017_bib13","article-title":"Mebendazole compared with secnidazole in the treatment of adult giardiasis: a randomised, no-inferiority, open clinical trial","volume":"2011","author":"Almirall","year":"2011","journal-title":"J\u00a0Parasitol Res"},{"key":"10.1016\/j.cmi.2019.12.017_bib14","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1185\/03007995.2011.637915","article-title":"Albendazole versus metronidazole in the treatment of adult giardiasis: a randomized, double-blind, clinical trial","volume":"28","author":"Canete","year":"2012","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.cmi.2019.12.017_bib15","doi-asserted-by":"crossref","first-page":"6366","DOI":"10.3748\/wjg.v12.i39.6366","article-title":"Randomized clinical study of five days apostrophe therapy with mebendazole compared to quinacrine in the treatment of symptomatic giardiasis in children","volume":"12","author":"Canete","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cmi.2019.12.017_bib16","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s40475-015-0051-1","article-title":"Drug resistance in the microaerophilic parasite giardia lamblia","volume":"2","author":"Leitsch","year":"2015","journal-title":"Curr Trop Med Rep"},{"key":"10.1016\/j.cmi.2019.12.017_bib17","doi-asserted-by":"crossref","first-page":"4643","DOI":"10.1128\/AAC.00384-11","article-title":"Impaired parasite attachment as fitness cost of metronidazole resistance in Giardia lamblia","volume":"55","author":"Tejman-Yarden","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2019.12.017_bib18","doi-asserted-by":"crossref","first-page":"378","DOI":"10.4103\/0255-0857.142236","article-title":"Refractory giardiasis: a molecular appraisal from a tertiary care centre in India","volume":"32","author":"Yadav","year":"2014","journal-title":"Indian J Med Microbiol"},{"key":"10.1016\/j.cmi.2019.12.017_bib19","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1093\/jac\/dkx430","article-title":"Comparative efficacy of drugs for treating giardiasis: a systematic update of the literature and network meta-analysis of randomized clinical trials","volume":"73","author":"Ordonez-Mena","year":"2018","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2019.12.017_bib20","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1086\/320886","article-title":"Treatment of patients with refractory giardiasis","volume":"33","author":"Nash","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2019.12.017_bib21","doi-asserted-by":"crossref","first-page":"171","DOI":"10.4269\/ajtmh.2010.09-0742","article-title":"Short course combination therapy for giardiasis after nitroimidazole failure","volume":"83","author":"Lopez-Velez","year":"2010","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.cmi.2019.12.017_bib22","first-page":"268","article-title":"Treatment-ladder and genetic characterisation of parasites in refractory giardiasis after an outbreak in Norway","volume":"56","author":"Morch","year":"2008","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.cmi.2019.12.017_bib23","first-page":"761","article-title":"[Synergic effect of albendazole plus metronidazole association in the treatment of metronidazole-resistant giardiasis]","volume":"146","author":"Cacopardo","year":"1995","journal-title":"Clin Ter"},{"key":"10.1016\/j.cmi.2019.12.017_bib24","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/jac\/dkx351","article-title":"Metronidazole: an update on metabolism, structure-cytotoxicity and resistance mechanisms","volume":"73","author":"Dingsdag","year":"2018","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2019.12.017_bib25","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1128\/CMR.14.1.150-164.2001","article-title":"Drug targets and mechanisms of resistance in the anaerobic protozoa","volume":"14","author":"Upcroft","year":"2001","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.cmi.2019.12.017_bib26","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1179\/000349803235002380","article-title":"A\u00a0randomized trial comparing mebendazole and secnidazole for the treatment of giardiasis","volume":"97","author":"Escobedo","year":"2003","journal-title":"Ann Trop Med Parasitol"},{"key":"10.1016\/j.cmi.2019.12.017_bib27","first-page":"113","article-title":"Nitazoxanide for the treatment of Giardia duodenalis infection: a comparative trial with secnidazole","volume":"67","author":"Gonz\u00e1lez","year":"2010","journal-title":"Turk Bull Hyg Exp Biol"},{"key":"10.1016\/j.cmi.2019.12.017_bib28","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1179\/136485908X267894","article-title":"The treatment of giardiasis in children: single-dose tinidazole compared with 3 days of nitazoxanide","volume":"102","author":"Escobedo","year":"2008","journal-title":"Ann Trop Med Parasitol"},{"key":"10.1016\/j.cmi.2019.12.017_bib29","first-page":"607","article-title":"A\u00a0randomized, controlled, open-label trial evaluating the efficacy and safety of chloroquine in the treatment of giardiasis in children","volume":"59","author":"Canete","year":"2010","journal-title":"West Indian Med J"},{"key":"10.1016\/j.cmi.2019.12.017_bib30","doi-asserted-by":"crossref","first-page":"134","DOI":"10.2174\/1574891X10666150914122118","article-title":"Chloroquine: an old drug with new perspective against giardiasis","volume":"10","author":"Escobedo","year":"2015","journal-title":"Recent Pat Antiinfect Drug Discov"},{"key":"10.1016\/j.cmi.2019.12.017_bib31","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1179\/000349803235002290","article-title":"Comparison of chloroquine, albendazole and tinidazole in the treatment of children with giardiasis","volume":"97","author":"Escobedo","year":"2003","journal-title":"Ann Trop Med Parasitol"},{"key":"10.1016\/j.cmi.2019.12.017_bib32","article-title":"Drugs for treating giardiasis","volume":"12","author":"Granados","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cmi.2019.12.017_bib33","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.trstmh.2008.11.029","article-title":"Mebendazole in parasitic infections other than those caused by soil-transmitted helminths","volume":"103","author":"Canete","year":"2009","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.cmi.2019.12.017_bib34","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1093\/infdis\/jix066","article-title":"The use of quinacrine in nitroimidazole-resistant giardia duodenalis: an old drug for an emerging problem","volume":"215","author":"Requena-Mendez","year":"2017","journal-title":"J\u00a0Infect Dis"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X19306743?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X19306743?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:25:31Z","timestamp":1761117931000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X19306743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":34,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S1198743X19306743"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2019.12.017","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"5-Nitroimidazole refractory giardiasis is common in Matanzas, Cuba and effectively treated by secnidazole plus high-dose mebendazole or quinacrine: a prospective observational cohort study","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2019.12.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}